Tag: biopharma

Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under Ind CEPI, implemented by BIRAC will soon move into clinical trials...............

While the union S&T minister, Dr Harsh Vardhan stated that in-silico drug discovery which utilizes computational methods such as Machine Learning, AI (Artificial Intelligence) and Big Data will help in accelerating this process.................

Instrumentation with improved reliability and accuracy will be key to facilitating higher productivity, revealed the survey where respondents included 650 laboratory managers, directors, and supervisors from China, Germany, India, South Korea, Switzerland, Austria, and the United States.......................

While approximately 21,000 hemophilic patients are registered in India, the ongoing government support, standards of care have improved in the country......................

Updated system meets challenges of India’s changing lab landscape................

Proven leader with more than 20 years of experience in the biopharmaceutical industry, Dr Mahender Nayak will continue to increase patient access to Takeda’s portfolio of highly innovative medicines..................

Speaking on the 2nd day of BioAsia 2020, Union Minister Mr Piyush Goyal said that the patent applications will be approved in record time to enable the industry to discover innovative drugs..................

Institute of Chemical Technology (ICT), Mumbai, is conducting the 3rd Biosimilar Workshop from February 3-8, 2020. Participants will also have the opportunity to hear from leaders of the Indian and global biopharma industry, providing a perspective on the training programs...............

Early combination treatment strategy with vildagliptin and metformin was superior to the standard of care in newly diagnosed type 2 diabetes patients. The landmark VERIFY study is the first to investigate the long-term clinical benefits of this early combination strategy in type 2 diabetes...................

Sun Pharma and China Medical System Holdings have entered into licensing agreement for generic products in Mainland China..............